Oncolix, Inc.
Pharmaceutical company · Houston, Texas, United States
Oncolix, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $4.2 million sold in a notice filed in 2017.
Oncolix at a glance
What does Oncolix do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $4.2 million sold (2017).
Frequently asked questions about Oncolix
Where is Oncolix headquartered?
Oncolix, Inc. is headquartered in Houston, Texas, United States.
What does Oncolix do?
Oncolix, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Oncolix founded?
The earliest incorporation on record for Oncolix, Inc. is in 2013, according to public company registers.
Similar companies
- Marker Therapeutics, Inc.Houston, Texas, United States
- 7 Hills Pharma Inc.Houston, Texas, United States
- Decoy Therapeutics Inc.Houston, Texas, United States
- CNS Pharmaceuticals, Inc.Houston, Texas, United States
- Coya Therapeutics, Inc.Houston, Texas, United States
- Aravive, Inc.Houston, Texas, United States
- Beta Cat Pharmaceuticals, Inc.Houston, Texas, United States
- Moleculin Biotech, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences